Seborrhea Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Seborrhea – Pipeline Review, H1 2015” to its store. The report provides an overview of the Seborrhea’s therapeutic pipeline.

Seborrhea Therapeutic Pipeline Review H1 2015

Seborrhea Therapeutic Pipeline Review H1 2015

Past News Releases

RSS

The report “Seborrhea – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Seborrhea. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/seborrhea-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Seborrhea and special features on late-stage and discontinued projects. Companies discussed in this Seborrhea – Pipeline Review, H1 2015 report include Biomar Microbial Technologies, EpiPharm AG, Maruho Co., Ltd. and Phosphagenics Limited.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are A-101, EPI-SK14, IB-07A081, IB-07A085, ketoconazole and lanoconazole. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=365326 . (This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases cover by this report include: Jan 27, 2015: Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Benign Skin Tumor 31 and Jun 30, 2014: Aclaris Therapeutics Announces Positive Results from Phase 2 Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Skin Tumor 31.

List of Tables
Number of Products under Development for Seborrhea, H1 2015 7
Number of Products under Development for Seborrhea - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Seborrhea - Pipeline by Biomar Microbial Technologies, H1 2015 13
Seborrhea - Pipeline by EpiPharm AG, H1 2015 14
Seborrhea - Pipeline by Maruho Co., Ltd., H1 2015 15
Seborrhea - Pipeline by Phosphagenics Limited, H1 2015 16
Assessment by Monotherapy Products, H1 2015 17
Number of Products by Stage and Target, H1 2015 18
Number of Products by Stage and Mechanism of Action, H1 2015 19
Number of Products by Stage and Route of Administration, H1 2015 20
Number of Products by Stage and Molecule Type, H1 2015 21
Seborrhea Therapeutics - Recent Pipeline Updates, H1 2015 28
Seborrhea - Dormant Projects, H1 2015 29
Seborrhea - Discontinued Products, H1 2015 30

List of Figures
Number of Products under Development for Seborrhea, H1 2015 7
Number of Products under Development for Seborrhea - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Assessment by Monotherapy Products, H1 2015 17
Number of Products by Stage and Top 10 Targets, H1 2015 18
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 19
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 20
Number of Products by Stage and Top 10 Molecule Types, H1 2015 21

Explore more reports on Dermatology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/dermatology-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website